Back to funds
View filing
Enavate Sciences GP, LLC
hedge fundUpdated 27 days agoManaged by Enavate Sciences Gp, Llc • Latest filing Q2 2026
Portfolio value
$345.4M
Q2 2026
Filings
7
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
264.0%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 7 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q4 2024 | $139.2M |
| Q1 2025 | $132.7M |
| Q2 2025 | $176.5M |
| Q3 2025 | $327.5M |
| Q4 2025 | $506.8M |
| Q1 2026 | $351.5M |
| Q2 2026 | $345.4M |
Top holdings
7 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | S SION SIONNA THERAPEUTICS INC | $109M | 2.48M | 31.56% | — |
| 2 | Z ZBIO ZENAS BIOPHARMA INC | $99.5M | 3.92M | 28.80% | — |
| 3 | I IMNM IMMUNOME INC | $76.6M | 3.61M | 22.17% | — |
| 4 | ? N/A BRIDGEBIO ONCOLOGY THERAPEUT | $20M | 2.63M | 5.80% | — |
| 5 | ? N/A COMPASS THERAPEUTICS INC | $17.1M | 7.79M | 4.94% | — |
| 6 | ? N/A UPSTREAM BIO INC | $17M | 2.46M | 4.93% | — |
| 7 | C CAMP CAMP4 THERAPEUTICS CORP | $6.2M | 1.43M | 1.80% | — |